SUPR
Next generation sequencing of the cancer cell lines and tumor spheroids-derived cancer cell lines
Dnr:

NAISS 2023/22-246

Type:

NAISS Small Compute

Principal Investigator:

Jenny Persson

Affiliation:

UmeƄ universitet

Start Date:

2023-03-06

End Date:

2024-04-01

Primary Classification:

30203: Cancer and Oncology

Webpage:

Allocation

Abstract

The on-going work is aimeding to validate biomarkers capable of predicting treatment response of cancer cells to combinational drug treatment. , We are use the data from genomic data and next generation sequencing data to do the bioinformatic analysis. This will enable us to obtain the signatures of the bimarkers. The next-generation sequencing has applied to the cells that are well suited. We have data generate that are comprehensive transcriptome profiles from cancer cells. The NGS data will need to be analyzed. We are using the cancer cell lines and cancer line-derived tumor spheriods to test the effects of the anticancer drugs in combination on the cancer growth and invasivness.